Moving On Autism - Latest News - And how you can help!

MBOS Newsletter - November 2020

Hi everyone! 
What a crazy year 2020 has been so far..  If even a fraction of the resources currently being spent on COVID-19 could be spent on autism, we could transform the levels of support, research and momentum driving improved life outcomes!
 
Since our last newsletter, we've been busy pushing out new research, working with a pair of autistic twin girls, and also grappling with the realities of funding broader clinical trials.  We are stepping up our communication and excited to share some key activities with you...  

2nd Paper Is Published
Our second peer-reviewed paper was published in May 2020, once again in Autism - Open Access.  In this paper we provide a hypothesis of what we believe is happening physiologically in the brain to create the results we obtained in the pilot study.  We hope this paper will spur further research into understanding this area, meanwhile we are staying focussed on the steps necessary to make the therapy available.

MBOS Research

Treating the Twins!
At the end of January 2020, we started treating twin 5-year old girls with autism - the youngest children we've worked with so far.  Based on their ATEC scores, they are classified as moderately affected, less impacted than three of the five boys in our earlier studies and half the age or less than any of them.
The girls are responding well to treatment, and whilst their rate of change has been slower than we saw in the older and more impacted boys, we have seen greater than a 30% reduction in the ATEC results so far.  It is very heartening to hear about the new things the girls are doing and how their focus and verbalization are improving. Current indications are we will see further improvements.
With the COVID-19 pandemic disrupting just about everything, we are grateful that our approach of creating a system that can be installed and used at home has proven effective, and the family has been able to maintain treatment without disruption.

Crowd Funding Campaign for Clinical Trials
Microbaric Oxygen Therapy is a broad-spectrum medical intervention which means that, even with our compelling pilot study results, we are not on the same page as “big pharma” with their schedule of psychotropic drugs, or ABA-based psychosocial therapies, or research identifying new genes that are in some way implicated in autism.  
 
We need to begin conducting the studies required to obtain regulatory compliance and make MBO2 generally available. So, we are now developing a crowdfunding campaign to raise the monies necessary to run broader clinical trials demonstrating both safety and treatment efficacy.
 
A crowdfunding campaign is only as successful as the number of people who choose to support and participate! 
 
Whilst we work to setup the campaign, we need your help to spread the word so we have maximum chance of success when we launch.
 
📱 🖥 ☎️ 📡 📢
We will be posting the newsletter on our social channels - please do click on any of social icons below and share our posts to your own network, or forward this newsletter to anyone interested.

Follow Us or Share With Your Network

More at microbaric.com

You are receiving this newsletter because you signed up via our website.  We aim to send newsletters on a monthly basis.  If you no longer wish to receive this email then please reply with message - unsubscribe and we will remove you from future communications.

This email was created with Wix.‌ Discover More